The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
Open accessAbstract
Idiopathic pulmonary fibrosis (IPF) is characterized by distorted lung architecture and loss of respiratory function. Enhanced (myo)fibroblast activation, ECM deposition, and alveolar epithelial type II (ATII) cell dysfunction contribute to IPF pathogenesis. However, the molecular pathways linking ATII cell dysfunction with the development of fibrosis are poorly understood. Here, we demonstrate, in a mouse model of pulmonary fibrosis, increased proliferation and altered expression of components of the WNT/beta-catenin signaling pathway in ATII cells. Further analysis revealed that expression of WNT1-inducible signaling protein-1 (WISP1), which is encoded by a WNT target gene, was increased in ATII cells in both a mouse model of pulmonary fibrosis and patients with IPF. Treatment of mouse primary ATII cells with recombinant WISP1 led to increased proliferation and epithelial-mesenchymal transition (EMT), while treatment of mouse and human lung fibroblasts with recombinant WISP1 enhanced deposition of ECM components. In the mouse model of pulmonary fibrosis, neutralizing mAbs specific for WISP1 reduced the expression of genes characteristic of fibrosis and reversed the expression of genes associated with EMT. More importantly, these changes in gene expression were associated with marked attenuation of lung fibrosis, including decreased collagen deposition and improved lung function and survival. Our study thus identifies WISP1 as a key regulator of ATII cell hyperplasia and plasticity as well as a potential therapeutic target for attenuation of pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, transcript level as well as secretion of the ATII cell-derived fibrotic mediator Wnt-inducible signalling protein (Wisp) 1 [26] were significantly reduced upon senolytic treatment (online supplementary figure S5C and figure 5d; DMSO 2.10±0.91-fold over control versus DQ 0.71±0.26-fold over control).”
From Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo (2017) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,807
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K. M., Lutz, M., Murray, L. A., Xue, Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20997 · Cited by 1,071
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
Willis, B. C., & Borok, Z. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00163.2007 · Cited by 1,064
Research works printed but not linked: 7
- Gharaee-Kermani, 2005, Methods Mol. Med., 117, 251
- Phan, 2003, Am. J. Respir. Cell Mol. Biol., 29, S87
- Kalluri, 2003, J. Clin. Invest., 112, 1776, 10.1172/JCI200320530 · DOI
- Uhal, 1998, Am. J. Physiol., 275, L1192
- Adamson, 1988, Am. J. Pathol., 130, 377
- Fukuda, 1985, Am. J. Pathol., 118, 452
- Phillips, 2004, J. Clin. Invest., 114, 438, 10.1172/JCI200420997 · DOI
Cited by
Sorted by citations
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,326
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,063
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 888
Epithelial repair mechanisms in the lung
Crosby, L. M., & Waters, C. M. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00361.2009 · Cited by 724
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 674
Self-citationTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Jun, J.-I., & Lau, L. F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3599 · Cited by 568
Pulmonary fibrosis: patterns and perpetrators
Noble, P. W., Barkauskas, C. E., & Jiang, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60323 · Cited by 595
Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
Xie, N., Tan, Z., Banerjee, S., Cui, H., Ge, J., Liu, R.-M., Bernard, K., Thannickal, V. J., & Liu, G. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0780oc · Cited by 582
Developmental pathways in the pathogenesis of lung fibrosis
Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., Langhe, S. D., & Thannickal, V. J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 525
Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis
Pandit, K. V., Corcoran, D. L., Yousef, H., Yarlagadda, M., Τzouvelekis, Α., Gibson, K. F., Konishi, K., Yousem, S. A., Singh, M. K., Handley, D., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1698oc · Cited by 510
Self-citationTGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
Su, J., Morgani, S. M., David, C. J., Wang, Q., Er, E. E., Huang, Y.-H., Basnet, H., Zou, Y., Shu, W., Soni, R. K., et al. (2020) · Nature · doi:10.1038/s41586-019-1897-5 · Cited by 503
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Wang, J., Hu, K., Cai, X., Yang, B., He, Q., Wang, J., & Weng, Q. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.023 · Cited by 476
Selman, M., & Pardo, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2221pp · Cited by 472
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
Dinh, P., Paudel, D., Brochu, H. N., Popowski, K. D., Gracieux-Singleton, M. C., Cores, J., Huang, K., Hensley, M. T., Harrell, E. A., Vandergriff, A. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14344-7 · Cited by 445
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Fernandez, I. E., & Eickelberg, O. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61144-1 · Cited by 455
Self-citationHinz, B. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.009 · Cited by 424
Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02367-2016 · Cited by 403
Self-citationThe interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Parimon, T., Yao, C., Stripp, B. R., Noble, P. W., & Chen, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072269 · Cited by 397
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis
Richards, T. J., Kaminski, N., Baribaud, F., Flavin, S., Brodmerkel, C., Horowitz, D., Li, K., Choi, J., Vuga, L. J., Lindell, K. O., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0058oc · Cited by 381
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Bhattacharyya, S., Wei, J., & Varga, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.149 · Cited by 381
Lukjanenko, L., Karaz, S., Stuelsatz, P., Gurriaran-Rodriguez, U., Michaud, J., Dammone, G., Sizzano, F., Mashinchian, O., Ancel, S., Migliavacca, E., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2018.12.014 · Cited by 374
Wnt signaling pathway: A comprehensive review
Hayat, R., Manzoor, M., & Hussain, A. (2022) · Cell Biology International · doi:10.1002/cbin.11797 · Cited by 379
Immune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
Self-citationMeiners, S., Eickelberg, O., & Königshoff, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00186914 · Cited by 340
Self-citationThe role of myofibroblasts in wound healing
Hinz, B. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.09.003 · Cited by 328
Duan, J., Gherghe, C. M., Liu, D., Hamlett, E. D., Srikantha, L., Rodgers, L., Regan, J. N., Rojas, M., Willis, M. S., Leask, A., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.418 · Cited by 315
Chilosi, M., Carloni, A., Rossi, A., & Poletti, V. E. (2013) · Translational research · doi:10.1016/j.trsl.2013.06.004 · Cited by 319
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
Sakai, N., & Tager, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.001 · Cited by 295
Targeting TGF-β signaling for the treatment of fibrosis
Györfi, A., Matei, A., & Distler, J. H. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.016 · Cited by 283
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. R. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 278
Schiller, H. B., Fernandez, I. E., Burgstaller, G., Schaab, C., Scheltema, R. A., Schwarzmayr, T., Strom, T. M., Eickelberg, O., & Mann, M. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156123 · Cited by 261
Self-citationZhou, B., Liu, Y., Kahn, M., Ann, D. K., Han, A., Wang, H., Nguyen, C., Flodby, P., Zhong, Q., Krishnaveni, M. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276311 · Cited by 260
Participation of miR-200 in Pulmonary Fibrosis
Yang, S., Banerjee, S., de Freitas, A., Sanders, Y. Y., Ding, Q., Matalon, S., Thannickal, V. J., Abraham, E. H., & Liu, G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.005 · Cited by 258
Königshoff, M., & Eickelberg, O. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0485tr · Cited by 262
Self-citationMatrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis
Yamashita, C. M., Dolgonos, L., Zemans, R. L., Young, S. K., Robertson, J. V., Briones, N. J., Suzuki, T., Campbell, M., Gauldie, J., Radisky, D. C., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.041 · Cited by 254
Yang, I. V., Coldren, C. D., Leach, S. M., Seibold, M. A., Murphy, E., Lin, J., Rosen, R. Z., Neidermyer, A. J., McKean, D. F., Groshong, S. D., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202943 · Cited by 247
Fibrosis: ultimate and proximate causes
Thannickal, V. J., Zhou, Y., Gaggar, A., & Duncan, S. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74368 · Cited by 249
Hansmann, G., Fernandez‐Gonzalez, A., Aslam, M. N., Vitali, S. H., Martin, T. R., Mitsialis, S. A., & Kourembanas, S. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.97603 · Cited by 233
Evans, C. M., Fingerlin, T. E., Schwarz, M. I., Lynch, D. A., Kurche, J. S., Warg, L. A., Yang, I. V., & Schwartz, D. A. (2016) · Physiological Reviews · doi:10.1152/physrev.00004.2016 · Cited by 243
Wei, J., Fang, F., Lam, A. P., Sargent, J. L., Hamburg, E., Hinchcliff, M. E., Gottardi, C. J., Atit, R., Whitfield, M. L., & Varga, J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34424 · Cited by 226
Zhou, X., Liu, S., Cai, G., Kong, L., Zhang, T., Ren, Y., Wu, Y., Mei, M., Zhang, L., & Wang, X. (2015) · Scientific Reports · doi:10.1038/srep15972 · Cited by 231
E-cadherin: gatekeeper of airway mucosa and allergic sensitization
Nawijn, M. C., Hackett, T., Postma, D. S., van Oosterhout, A. J. M., & Heijink, I. H. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.004 · Cited by 222
Wei, J., Melichian, D., Komura, K., Hinchcliff, M., Lam, A. P., Lafyatis, R., Gottardi, C. J., MacDougald, O. A., & Varga, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30312 · Cited by 214
Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling.
Quirós, M., Nishio, H., Neumann, P., Siuda, D., Brazil, J., Azcutia, V., Hilgarth, R., O'Leary, M. N., Garcia-Hernandez, V., Leoni, G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90229 · Cited by 169
Novel therapeutic approaches for pulmonary fibrosis
Datta, A., Scotton, C. J., & Chambers, R. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01247.x · Cited by 205
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Oncotarget · doi:10.18632/oncotarget.21234 · Cited by 211
Dees, C., Schlottmann, I., Funke, R., Distler, A., Palumbo‐Zerr, K., Zerr, P., Lin, N., Beyer, C., Distler, O., Schett, G. A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203194 · Cited by 209
Activation of the WNT/β-Catenin Pathway Attenuates Experimental Emphysema
Kneidinger, N., Yildirim, A. Ö., Callegari, J., Takenaka, S., Stein, M. M., Dumitrascu, R., Bohla, A., Bracke, K. R., Morty, R. E., Brusselle, G., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200910-1560oc · Cited by 203
Self-citationHou, J., Ma, T., Cao, H., Chen, Y., Wang, C., Chen, X., Xiang, Z., & Han, X. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26112 · Cited by 194
Neutrophil transmigration triggers repair of the lung epithelium via β-catenin signaling
Zemans, R. L., Briones, N. J., Campbell, M., McClendon, J. D., Young, S. K., Suzuki, T., Yang, I. V., Langhe, S. D., Reynolds, S. D., Mason, R. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110144108 · Cited by 189
Lietman, C., Wu, B., Lechner, S., Shinar, A. A., Sehgal, M., Rossomacha, E., Datta, P., Sharma, A., Gandhi, R., Kapoor, M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96308 · Cited by 189
The pathogenesis of COPD and IPF: Distinct horns of the same devil?
Chilosi, M., Poletti, V. E., & Rossi, A. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-3 · Cited by 187
WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis
Aumiller, V., Balsara, N., Wilhelm, J., Günther, A., & Königshoff, M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0524oc · Cited by 186
Self-citationThe WNT signaling pathways in wound healing and fibrosis
Burgy, O., & Königshoff, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.017 · Cited by 175
Self-citation‘WNT-er is coming’: WNT signalling in chronic lung diseases
Baarsma, H. A., & Königshoff, M. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209753 · Cited by 179
Self-citationNoncanonical WNT-5A signaling impairs endogenous lung repair in COPD
Baarsma, H. A., Skrońska-Wąsek, W., Mutze, K., Ciolek, F., Wagner, D. E., John-Schuster, G., Heinzelmann, K., Günther, A., Bracke, K. R., Dagouassat, M., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160675 · Cited by 177
Self-citationBaarsma, H. A., Königshoff, M., & Gosens, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.002 · Cited by 179
Self-citationFibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy
Wei, J., Bhattacharyya, S., Tourtellotte, W. G., & Varga, J. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.015 · Cited by 179
Profibrotic Role of miR-154 in Pulmonary Fibrosis
Milošević, J., Pandit, K. V., Magister, M. J., Rabinovich, E., Ellwanger, D. C., Yu, G., Vuga, L. J., Weksler, B., Benos, P. V., Gibson, K. F., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0377oc · Cited by 174
Inhibition of LTβR signalling activates WNT-induced regeneration in lung
Conlon, T. M., John-Schuster, G., Heide, D., Pfister, D. R., Lehmann, M., Hu, Y., Ertüz, Z., Lopez, M., Ansari, M., Strunz, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2882-8 · Cited by 178
Self-citationLung cancer in patients with idiopathic pulmonary fibrosis
Karampitsakos, Τ., Tzilas, V., Tringidou, R., Steiropoulos, P., Aidinis, V., Papiris, S. A., Bouros, D. E., & Τzouvelekis, Α. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.03.016 · Cited by 173
Epithelial Barrier Dysfunction in Chronic Respiratory Diseases
Carlier, F. M., Fays, C. D., & Pilette, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.691227 · Cited by 181
Mechanical stress induces lung fibrosis by epithelial–mesenchymal transition*
Cabrera-Benítez, N. E., Parotto, M., Post, M., Han, B., Spieth, P. M., Cheng, W.-E., Valladares, F., Villar, J., Liu, M., Sato, M., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822f09d7 · Cited by 166
Wnt signaling in lung development, regeneration, and disease progression
Aros, C. J., Pantoja, C. J., & Gomperts, B. N. (2021) · Communications Biology · doi:10.1038/s42003-021-02118-w · Cited by 171
Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures
Uhl, F. E., Vierkotten, S., Wagner, D. E., Burgstaller, G., Costa, R., Koch, I., Lindner, M., Meiners, S., Eickelberg, O., & Königshoff, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00183214 · Cited by 173
Self-citationKubota, S., & Takigawa, M. (2014) · Clinical Science · doi:10.1042/cs20140264 · Cited by 169
miR‐145 regulates myofibroblast differentiation and lung fibrosis
Yang, S., Cui, H., Xie, N., Icyuz, M., Banerjee, S., Antony, V. B., Abraham, E. H., Thannickal, V. J., & Liu, G. (2013) · The FASEB Journal · doi:10.1096/fj.12-219493 · Cited by 171
Role of Sonic Hedgehog in idiopathic pulmonary fibrosis
Lozano, A., Mendoza-Milla, C., Cisneros, J., Ramírez, R., Checa, M., Barrera, L., García, J. A., Carbajal, V., Becerril, C., Gaxiola, M., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00184.2012 · Cited by 165
Baarsma, H. A., Spanjer, A. I. R., Haitsma, G., Engelbertink, L. H. J. M., Meurs, H., Jonker, M. R., Timens, W., Postma, D. S., Kerstjens, H. A. M., & Gosens, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025450 · Cited by 157
Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis
Kropski, J. A., Lawson, W. E., Young, L. R., & Blackwell, T. S. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010736 · Cited by 161
Wu, C., Tsai, Y., Wu, M.-Z., Teng, S., & Wu, K. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.05.005 · Cited by 156
Lam, A. P., Flozak, A. S., Russell, S., Wei, J., Jain, M., Mutlu, G. M., Budinger, G. R. S., Feghali‐Bostwick, C. A., Varga, J., & Gottardi, C. J. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0113oc · Cited by 156
Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis
Bickelhaupt, S., Erbel, C., Timke, C., Wirkner, U., Dadrich, M., Flechsig, P., Tietz, A., Pföhler, J., Groß, W., Peschke, P., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw339 · Cited by 153
Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling
Satoh, M., Nagasu, H., Morita, Y., Yamaguchi, T. P., Kanwar, Y. S., & Kashihara, N. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00460.2012 · Cited by 149
Schneider, D. J., Wu, M., Le, T. T., Cho, S., Brenner, M. B., Blackburn, M. R., & Agarwal, S. K. (2011) · The FASEB Journal · doi:10.1096/fj.11-186098 · Cited by 148
Heise, R. L., Stober, V. P., Cheluvaraju, C., Hollingsworth, J. W., & Garantziotis, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137273 · Cited by 149
Lung Repair and Regeneration in ARDS
Villar, J., Zhang, H., & Slutsky, A. S. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.10.022 · Cited by 143
Epigenetics of idiopathic pulmonary fibrosis
Yang, I. V., & Schwartz, D. A. (2014) · Translational research · doi:10.1016/j.trsl.2014.03.011 · Cited by 144
Cigna, N., Moshai, E. F., Brayer, S., Marchal-Sommé, J., Wémeau-Stervinou, L., Fabre, A., Mal, H., Lesèche, G., Dehoux, M., Soler, P., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.019 · Cited by 147
Cao, H., Wang, C., Chen, X., Hou, J., Xiang, Z., Shen, Y., & Han, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-28968-9 · Cited by 140
YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells
Chuyi, Z., Zhu, X., Hua, Y., Zhao, Q., Wang, K., Zhen, L., Wang, G., Lü, J., Luo, A., Cho, W. C. S., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1223-7 · Cited by 137
Kolosova, I. A., Nethery, D. E., & Kern, J. A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22448 · Cited by 141
Lehmann, M., Buhl, L., Alsafadi, H. N., Klee, S., Hermann, S., Mutze, K., Ota, C., Lindner, M., Behr, J., Hilgendorff, A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0876-y · Cited by 136
Self-citationWISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity
Ono, M., Inkson, C. A., Kilts, T. M., & Young, M. F. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.205 · Cited by 138
Wang, K., Zhang, T., Lei, Y., Li, X., Jiang, J., Lan, J., Liu, Y., Chen, H., Gao, W., Xie, N., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1409405 · Cited by 134
Chronic WNT/β-catenin signaling induces cellular senescence in lung epithelial cells
Lehmann, M., Hu, Q., Hu, Y., Hafner, K., Costa, R., van den Berg, A., & Königshoff, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109588 · Cited by 134
Self-citationFGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway
Ramos, C., Becerril, C., Montaño, M., de Alba, C. G., Ramı́rez, R., Checa, M., Pardo, A., & Selman, M. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00070.2010 · Cited by 131
Günsel, G. G., Conlon, T. M., Jeridi, A., Kim, R., Ertüz, Z., Lang, N. J., Ansari, M., Novikova, M., Jiang, D., Strunz, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28809-4 · Cited by 136
Self-citationCigarette smoke extract affects mitochondrial function in alveolar epithelial cells
Ballweg, K., Mutze, K., Königshoff, M., Eickelberg, O., & Meiners, S. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00180.2014 · Cited by 128
Self-citationCui, W., Zhang, Z., Zhang, P., Qu, J., Zheng, C., Mo, X., Zhou, W., Xu, L., Yao, H., & Gao, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13628 · Cited by 128
The Wnt/beta‐catenin pathway is activated during advanced arterial aging in humans
Marchand, A., Atassi, F., Gaaya, A., Leprince, P. N., Feuvre, C. L., Soubrier, F., Lompré, A., & Nadaud, S. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00661.x · Cited by 126
Shi, J., Li, F., Luo, M., Wei, J., & Liu, X. (2017) · Mediators of Inflammation · doi:10.1155/2017/3520581 · Cited by 129
Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis
Lega, J.-C., Lacasse, Y., Lakhal, L., & Provencher, S. (2009) · Thorax · doi:10.1136/thx.2008.110965 · Cited by 124
Blockade of the Wnt/.BETA.-Catenin Pathway Attenuates Bleomycin-Induced Pulmonary Fibrosis
Kim, T., Kim, S., Seo, J.-Y., Chung, H., Kwak, H. J., Lee, S., Yoon, H. J., Shin, D. H., Park, S. S., & Sohn, J. W. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.223.45 · Cited by 125
Flozak, A. S., Lam, A. P., Russell, S., Jain, M., Peled, O. N., Sheppard, K. A., Beri, R., Mutlu, G. M., Budinger, G. R. S., & Gottardi, C. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070326 · Cited by 123
Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
Selman, M., López-Otín, C., & Pardo, A. (2016) · European Respiratory Journal · doi:10.1183/13993003.00398-2016 · Cited by 122
Metadata
- Authors
- Königshoff, M., Kramer, M., Balsara, N., Wilhelm, J., Amarie, O. V., Jahn, A., Rose, F., Fink, L., Seeger, W., Schaefer, L., Günther, A., & Eickelberg, O.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Philipps University of Marburg (DE)
- Goethe University Frankfurt (DE)
- Helmholtz Munich (DE)
- Corresponding author
- Eickelberg, Oliver
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2009-03-16
- Volume
- 119
- Issue
- 4
- Pages
- 772-87
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2662540
- OpenAlex
- W2157101382
- Cited by
- 558
- References
- 72
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 22 · 2022: 25 · 2021: 27 · 2020: 36 · 2019: 26 · 2018: 44 · 2017: 41 · 2016: 53 · 2015: 42 · 2014: 33 · 2013: 42 · 2012: 40
- FWCI
- 30.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Alexander von Humboldt-Stiftung
- Deutsche Forschungsgemeinschaft
- Helmholtz Zentrum München
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- WISP1, idiopathic pulmonary fibrosis, alveolar type II cells, Wnt/β-catenin signaling, epithelial-mesenchymal transition, extracellular matrix deposition, myofibroblast activation, collagen deposition, pulmonary fibrosis, therapeutic target, neutralizing antibodies
- MeSH terms
- Adult, Animals, Bleomycin, Disease Models, Animal, Epithelial Cells, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Middle Aged, Models, Biological, Proto-Oncogene Proteins, Pulmonary Alveoli, Pulmonary Fibrosis, Recombinant Proteins, Oncogene Proteins, Up-Regulation, Intracellular Signaling Peptides and Proteins, Cell Proliferation, Wnt Proteins, beta Catenin, Mice, Idiopathic Pulmonary Fibrosis, CCN Intercellular Signaling Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
